Physician profile
Phillip M Devlin
NPI 1336105584
$2,928.01
in general payments reported to CMS, 2019-2025
8 companies · $1,157 in 2025
The $1,157 reported for 2025 was more than what 85% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $140 · 2020: $89.37 · 2021: $560 · 2022: $91.57 · 2023: $328 · 2024: $562 · 2025: $1,157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,170 · Travel and Lodging: $877.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,170.32 |
| Travel and Lodging | $876.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gt Medical Technologies, INC | $1,420.80 | 2022-2025 | Gammatile, Gammatile |
| Isoray, INC | $901.11 | 2019-2023 | Brachytherapy Source |
| Theragenics Corporation | $256.61 | 2024 | |
| Bioprotect Medical, INC. | $116.08 | 2024 | Bioprotect Balloon Implant System |
| Philips North America LLC | $87.20 | 2019-2024 | (Br0) Coronary Atherectomy |
| Palette Life Sciences, INC. | $74.32 | 2023 | |
| Boston Scientific Corporation | $53.34 | 2024 | Spaceoar System |
| Elekta, INC. | $18.55 | 2025 | Flexitron Hdr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phillip Devlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.